CYTK
Cytokinetics, Incorporated · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +11.8% ·
aliran saham +3.0% ·
posisi baru bersih +5.3%
· formula
Akumulasi luas: saham yang meningkat di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 11.48K | $711,878 | n/a | n/a |
| Q2 2026 | 126 | +7 | 95.69M | $8.15B | +10 | −4 |
| Q1 2026 | 123 | +1 | 87.96M | $5.79B | +8 | −8 |
| Q4 2025 | 121 | -1 | 92.45M | $5.87B | +2 | −2 |
| Q3 2025 | 19 | +2 | 69.14M | $3.80B | +2 | −1 |
| Q2 2025 | 15 | -2 | 62.06M | $2.05B | n/a | −2 |
| Q1 2025 | 14 | +1 | 26.36M | $1.06B | +1 | n/a |
| Q4 2024 | 13 | -1 | 25.19M | $1.18B | n/a | −1 |
| Q3 2024 | 13 | +2 | 19.21M | $1.01B | +2 | n/a |
| Q2 2024 | 11 | n/a | 17.42M | $943.61M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 15.53M | -1.0% | $853.30M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | Fidelity (FMR) ✦ | 13.09M | +16.2% | $719.52M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | The Vanguard Group ✦ (pasif) | 11.86M | -1.1% | $651.65M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | Wellington Management ✦ | 7.41M | -5.3% | $407.17M | 0.1% | ▼ Trim | 6 | SEC ↗ ×8 |
| 5 | State Street Global Advisors ✦ (pasif) | 5.62M | -11.8% | $308.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 3.09M | n/a | $169.59M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 7 | Geode Capital Management ✦ (pasif) | 3.04M | +1.5% | $167.11M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | T. Rowe Price ✦ | 2.37M | +26.8% | $130.08M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 1.63M | n/a | $89.84M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 10 | Morgan Stanley ✦ | 1.52M | n/a | $83.60M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | Citadel Advisors ✦ | 1.39M | +6.7% | $76.18M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Fisher Asset Management ✦ | 761.59K | +3.8% | $41.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 513.29K | +47.6% | $28.21M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 14 | Point72 Asset Management ✦ | 471.48K | Baru | $25.91M | 0.1% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 342.53K | -25.3% | $18.83M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 289.97K | +2752.0% | $15.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Marshall Wace ✦ | 178.98K | +743.2% | $9.84M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | Adage Capital Partners ✦ | 38.00K | Baru | $2.09M | 0.0% | New | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 13.60K | -28.7% | $747,621 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $25.91M | 0.1% |
| Adage Capital Partners | $2.09M | 0.0% |
Telah keluar
| Norges Bank | $39.12M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 437 pemegang, 145.17M saham, $8.22B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 3.50K lbr · $224,035
Officer, Director · 7.50K lbr · $471,600
Officer · 3.50K lbr · $214,830
Officer, Director · 7.50K lbr · $490,950
Officer · 3.50K lbr · $239,015
Officer, Director · 97.93K lbr · $6.79M
Director · 1.00K lbr · $72,130
Officer, Director · 7.50K lbr · $550,800
Director · 1.00K lbr · $74,660
Officer · 3.50K lbr · $264,110
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi